StonvexLoading…
StonvexStonvexStonvexCore line items from CTOR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 |
|---|---|---|
Revenue | $5.61M | $3.94M |
Operating Income | $-33.87M | $-5.25M |
Net Income | $-32.14M | $-5.53M |
EPS (Diluted) | $-0.34 | $-0.06 |
Total Assets | $100.70M | $109.97M |
Total Liabilities | $65.43M | $51.56M |
Cash & Equivalents | $2.63M | $7.30M |
Free Cash Flow OCF − CapEx | Not available | Not available |
Shares Outstanding | 92.98M | 84.80M |